Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00768690 · ClinicalTrials.gov registry record · Phase 1
A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333
A Phase 1 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 1
- Development phase
- 45
- Enrollment target
NCT00768690 is a Phase 1 study that has completed, run by Abbott. The registered enrollment target is 45 participants.
The verdict
NCT00768690, a Phase 1 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to determine multiple dose safety, tolerability and pharmacokinetics of ABT-333 under nonfasting conditions in healthy adult subjects, and to determine the effect of single dose administration of ketoconazole on steady state ABT-333 pharmacokinetics
Interventions
- DRUG placebo
- DRUG ketoconazole
- DRUG ABT-333
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2008-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00768690
The ClinicalTrials.gov registry entry for NCT00768690 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00768690 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00768690 about?
NCT00768690 is a clinical study titled "A Study in Healthy Adult Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333". The purpose of this study is to determine multiple dose safety, tolerability and pharmacokinetics of ABT-333 under nonfasting conditions in healthy adult subjects, and to determine the effect of single dose administration of ketoconazole on steady state ABT-333 pharmacokinetics
What is the current status of trial NCT00768690?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 2008-10.
What interventions are being tested in trial NCT00768690?
The interventions under investigation include: placebo (DRUG), ketoconazole (DRUG), ABT-333 (DRUG).
Who is sponsoring clinical trial NCT00768690?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.